Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Mazdutide for Sale > Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - large image1
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image1
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image2
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image3
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image4
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image5
Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management buy - image6

Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management

5 Inquiries

Unit Price:

$197/UNIT FOB

Get Latest Price
CAS No.:

2259884-03-0

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

ZhongMa

Packaging:

10mg per vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2027-02-27

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,Retatrutide,Tirzepatide,Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Una
    whatsapp:+8618830993261
    Email: Una@hzzmtrade.cn

    Items Specifications
    Product Name Mazdutide
    Appearance White freeze-dried powder
    Specification 10mg 
    Purity >99%



    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 1


    Mazdutide (IBI362) belongs to the peptide class of medicines and is a synthetic form of the naturally occurring hormone oxyntomodulin (OXM).

    Through its dual-target action, it stimulates both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR), bringing about a range of beneficial effects on metabolism.

    Its primary uses lie in managing type 2 diabetes and obesity. The compound supports weight loss by helping regulate appetite and energy balance, while also contributing to improved blood sugar control. Clinical evidence shows that Mazdutide effectively lowers blood glucose and helps patients achieve weight reduction.



    Company Profile


    Hangzhou ZhongMa Biotechnology Co., Ltd. is a biotech enterprise focused on the research, development, and supply of peptide products alongside made-to-order solutions. Backed by an experienced technical team and a quality-first management philosophy, we support clients in scientific research, pharmaceutical development, and other life-science fields.Our portfolio includes peptide raw materials, research-grade peptides, and customized peptide development services. Every stage — from raw-material sourcing and production coordination through quality inspection to final delivery — operates under clearly defined control procedures, ensuring consistent quality and a dependable supply.As market conditions and project requirements evolve, we continuously refine our technical expertise and service workflows to deliver practical solutions across a wide range of R&D needs.ZhongMa Biotechnology operates on the principles of quality, integrity, fast response, and lasting partnership. Through close communication with customers and a clear understanding of their requirements, we provide professional support for both standard catalog items and custom projects.Looking ahead, we will continue strengthening our capabilities in peptide technology, quality management, and customer care, with the goal of becoming a trusted global biotechnology partner — offering reliable products, attentive service, and sustainable value to life-science research customers worldwide.


    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 2

    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 3



    Product Application  


    1. Promotes slower emptying of the stomach, helping food stay in place longer
    2. Supports the liver in reducing excess sugar output
    3. Supports the pancreas in secreting more blood-sugar-lowering hormone in response to elevated glucose levels
    4. Contributes to maintaining blood glucose within a healthy range
    5. Helps ease post-meal blood sugar spikes (postprandial hyperglycemia)
    6. Helps keep fasting glucose and fasting blood sugar at healthier, lower levels
    7. Supports a reduction in hemoglobin A1c levels
    8. Helps curb appetite and reduce calorie consumption, supporting weight management
    9. Has been shown to help lower triglycerides and ease oxidative stress linked to elevated LDL cholesterol


    10. Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 4

    11. Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 5


    Product Benefit


    By acting on the appetite-regulating region of the brain, it strengthens the sensation of satiety, prompting individuals to consume smaller portions and keep their daily calorie intake under control.

    It may also boost energy expenditure by elevating the basal metabolic rate, so more calories are burned even at rest. This supports body weight reduction and holds particular value for people with type 2 diabetes who are overweight or obese.

    Some studies have pointed to a possible cardioprotective benefit, likely driven by a combination of factors—improved blood sugar, blood pressure, and lipid levels, along with weight loss—all of which help lower the risk of cardiovascular events. That said, further research and clinical validation are still needed to confirm this benefit.


    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 6



    Product Specifications & Packaging

    To support different laboratory and research requirements, this product is available in a range of specifications. Each vial is individually packed, and each box contains 10 vials for convenient storage, handling, and inventory management.

    Available Specifications:

    10mg/vial, 10 vials/box



    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 7




      1. Quality Assurance


      1. We operate a rigorous quality management system, deliver professional services, and maintain an outstanding reputation across the industry.


      2. Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 8




    Why Choose Us


    Our Key Advantages Reliable Quality & Competitive Value — We are committed to consistent product standards and competitive pricing, helping customers strike a practical balance between quality and procurement costs. Fast & Dependable Shipping — Through close collaboration with experienced logistics partners, we ensure efficient order processing and reliable delivery arrangements to keep shipments moving without delay. Transparent Order Management — Clear communication runs through the entire process, from order confirmation and preparation to dispatch and final delivery, so customers can always track the progress of their orders. Prompt & Professional Support — Our service team responds quickly to inquiries and provides efficient technical guidance and after-sales assistance whenever needed. Flexible Customized Services — Backed by experienced technical and service teams, we deliver tailored solutions to match different specifications, purchasing requirements and individual project needs. Strict Production & Quality Standards — From carefully selected raw materials and well-maintained equipment to trained personnel and controlled production procedures, every stage is managed with attention to consistency, reliability and stable product quality.


    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 9




    Q&A 



    Q: How soon can I receive my order?

    A: We will arrange shipment as quickly as possible after payment is confirmed. Delivery usually takes approximately 7–15 days, depending on the destination and logistics conditions.


    Q: What is the minimum order quantity?

    A: The minimum order quantity is 1 box, and each box contains 10 individually packed vials.


    Q: Can the price be adjusted?

    A: Yes. We always aim to provide customers with competitive pricing. The final price may vary depending on the selected specification, order quantity, and other purchasing requirements. Please contact us for a detailed quotation.


    Q: How should peptide products be transported and stored?

    A: Peptide products in lyophilized powder form can be transported at room temperature in sealed vacuum packaging. Products in dissolved form should be kept refrigerated at 2°C–8°C.


    For long-term storage, it is recommended to keep the lyophilized powder sealed with desiccant at −20°C or −80°C. Proper storage helps maintain product stability and  minimize degradation.


    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 10




    Shipping Methods


    ZHONGMA TECHNOLOGY — Global Logistics Solutions

    At ZHONGMA Technology, we ensure worldwide delivery of your orders through three well-established shipping channels:

    • Air Freight — An efficient and reliable option for time-sensitive consignments, ensuring rapid, secure transportation to the destination.

    • Sea Freight — A cost-effective solution for large-volume and bulk cargo, ideal for international shipments that prioritize economy and capacity.

    • Express Delivery — Door-to-door courier service in partnership with world-class providers including DHL, FedEx, UPS, EMS, and TNT, offering real-time tracking and dependable last-mile delivery.
    Backed by a global logistics network spanning multiple continents, ZHONGMA Technology delivers flexible, end-to-end shipping solutions tailored to your business requirements—wherever you are, and whatever you ship.


    Shop Mazdutide : The First Approved GCG/GLP-1 Dual Receptor Agonist for Once-Weekly Weight Management-Detailed Image 11
    ECHEMI Editorial Reference

    Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Mazdutide

    Other Name:

    Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)

    CAS No.:

    2259884-03-0

    Molecular Weight:

    0

    EC Number:

    884-103-0

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Dual GLP-1R/GCGR agonist (long-acting peptide)

    Status:

    Investigational — Phase 3 (China)

    Mechanism:

    A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.

    EC50 (GLP1R Ki):

    28.6 nM

    EC50 (GCGR Ki):

    17.7 nM

    Source:

    GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI

    Clinical Development:

    NCT04930343; NCT05592656

    References
    PubChem:

    PubChem

    Disclaimer:

    Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Tirzepatide,Peptides

    Location:

    Room A008, 704#, Building 11, Shiliu Street Block, Liangzhu Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    5 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Mazdutide

    25 MG Aug 12, 2026
    Nigeria

    Mazdutide 10mg

    20 PCS Mar 7, 2026
    United States

    Mazdutide

    30 MG Jul 15, 2024
    United Kingdom

    Mazdutide

    1 KG Feb 10, 2026
    United States

    Mazddultide cas

    2 MT Nov 14, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.